Crossmark

Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension

Crossref DOI link: https://doi.org/10.1038/s41598-020-65255-y

Published Online: 2020-05-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mishra, Mudit

Muthuramu, Ilayaraja

Kempen, Herman

De Geest, Bart
License Information

Text and Data Mining valid from 2020-05-20

Version of Record valid from 2020-05-20
More Information

Article History

Received: 22 January 2020

Accepted: 2 May 2020

First Online: 20 May 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below